... initiation of therapy. The aim of our study was to assess the reliability of a routinely performed screening examination. Patients and Methods: Newborns were examined by a pediatrician between 48 and 72 h after birth. Boys with suspected cryptorchidism were double-checked by a pediatric urologist within 24 h...

...Matthew B. Clements; Basil Abdalla; Stephen H. Culp; Raymond A. Costabile; Tracey L. Krupski Background: In May 2012, the US Preventive Services Task Force assigned prostate-specific antigen-based screening a grade D recommendation, advising against screening at any age. Our objective...

... aggressiveness and selection of patients eligible for conservative management. Two factors limiting the clinical implementation of validated biomarker candidates are costs and local availability. For these reasons, currently, their true clinical role starts after routine screening with prostate-specific antigen...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Urokinase Prostate cancer Screening 23 09 1993 12 10...

... and high monetary and human costs of the test and by the lack of proof that treatment is effective for those tumors detected. One must conclude that universal screening is not now warranted and will await demonstration of effectiveness by controlled studies. 2 2 2010 © 1991 S. Karger AG, Basel...